Overview A Study to Investigate the Safety and Efficacy of BOL-303224 in the Treatment of Bacterial Conjunctivitis Status: Completed Trial end date: 2007-07-01 Target enrollment: Participant gender: Summary This is a study to investigate a novel drug candidate for the treatment of bacterial conjunctivitis. Phase: Phase 3 Details Lead Sponsor: Bausch & Lomb IncorporatedTreatments: 7-(3-aminohexahydro-1H-azepin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acidBesifloxacinFluoroquinolonesMoxifloxacinNorgestimate, ethinyl estradiol drug combinationOphthalmic SolutionsPharmaceutical Solutions